153 related articles for article (PubMed ID: 37605162)
1. Impact of the COVID-19 pandemic on population-based cancer screening, a nationwide retrospective study in Taiwan.
Su CH; Hsu PS; Lin CS
BMC Health Serv Res; 2023 Aug; 23(1):878. PubMed ID: 37605162
[TBL] [Abstract][Full Text] [Related]
2. Changes in cancer screening process in primary care during the covid-19 pandemic.
Atadağ YB; Türkmen AT; Öksüz A; Keten HS; Aydin MR
Saudi Med J; 2023 Jun; 44(6):621-624. PubMed ID: 37343993
[TBL] [Abstract][Full Text] [Related]
3. Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study.
Nonboe MH; Napolitano G; Schroll JB; Vejborg I; Waldstrøm M; Lynge E
Elife; 2023 Mar; 12():. PubMed ID: 36943035
[TBL] [Abstract][Full Text] [Related]
4. Different impacts of cancer types on cancer screening during COVID-19 pandemic in Taiwan.
Shen CT; Hsieh HM; Chang YL; Tsai HY; Chen FM
J Formos Med Assoc; 2022 Oct; 121(10):1993-2000. PubMed ID: 35227585
[TBL] [Abstract][Full Text] [Related]
5. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
[TBL] [Abstract][Full Text] [Related]
6. A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
Joung RH; Nelson H; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Brajcich BC; Bilimoria KY; Cance WG
Cancer; 2022 Jun; 128(11):2119-2125. PubMed ID: 35307815
[TBL] [Abstract][Full Text] [Related]
7. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
[TBL] [Abstract][Full Text] [Related]
8. Changes in cancer screening before and during COVID-19: findings from the Korean National Cancer Screening Survey 2019 and 2020.
Trinh TTK; Lee YY; Suh M; Jun JK; Choi KS
Epidemiol Health; 2022; 44():e2022051. PubMed ID: 35638224
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
[TBL] [Abstract][Full Text] [Related]
10. Impact of COVID-19 in Cervical and Breast Cancer Screening and Systemic Treatment in São Paulo, Brazil: An Interrupted Time Series Analysis.
Duarte MBO; Argenton JLP; Carvalheira JBC
JCO Glob Oncol; 2022 Jun; 8():e2100371. PubMed ID: 35696624
[TBL] [Abstract][Full Text] [Related]
11. Effects of the COVID-19 pandemic on breast cancer screening in Taiwan.
Tsai HY; Chang YL; Shen CT; Chung WS; Tsai HJ; Chen FM
Breast; 2020 Dec; 54():52-55. PubMed ID: 32919172
[TBL] [Abstract][Full Text] [Related]
12. Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.
Machii R; Takahashi H
Cancer Epidemiol; 2023 Feb; 82():102313. PubMed ID: 36508964
[TBL] [Abstract][Full Text] [Related]
13. Outcome of the randomized control screening trials on oral, cervix and breast cancer from India and way forward in COVID-19 pandemic situation.
Budukh AM; Dikshit R; Chaturvedi P
Int J Cancer; 2021 Oct; 149(8):1619-1620. PubMed ID: 34152021
[No Abstract] [Full Text] [Related]
14. Impact of COVID-19 on Primary Care Quality Measures in an Academic Integrated Health System.
Kim E; Kojima N; Vangala S; Dermenchyan A; Lambrechts S; Grossman M; Han M; Croymans DM
J Gen Intern Med; 2022 Apr; 37(5):1161-1168. PubMed ID: 35083647
[TBL] [Abstract][Full Text] [Related]
15. The Short-Term Impact Of COVID-19 Pandemic on Cervical Cancer Screening: A Systematic Review and Meta-Analysis.
Sasidharanpillai S; Ravishankar N
Asian Pac J Cancer Prev; 2022 May; 23(5):1497-1504. PubMed ID: 35633530
[TBL] [Abstract][Full Text] [Related]
16. Examining the perceived impact of the COVID-19 pandemic on cervical cancer screening practices among clinicians practicing in Federally Qualified Health Centers: A mixed methods study.
Fuzzell L; Lake P; Brownstein NC; Fontenot HB; Whitmer A; Michel A; McIntyre M; Rossi SL; Kajtezovic S; Vadaparampil ST; Perkins R
Elife; 2023 Sep; 12():. PubMed ID: 37664989
[TBL] [Abstract][Full Text] [Related]
17. Geographic Examination of COVID-19 Test Percent Positivity and Proportional Change in Cancer Screening Volume, National Breast and Cervical Cancer Early Detection Program.
Bermudez Y; Scott LC; Beckman M; DeGroff A; Kenney K; Sun J; Rockwell T; Helsel W; Kammerer W; Sheu A; Miller J; Richardson LC
Prev Chronic Dis; 2022 Sep; 19():E59. PubMed ID: 36108291
[TBL] [Abstract][Full Text] [Related]
18. Cancer screenings during the COVID-19 pandemic: An analysis of public interest trends.
Greiner B; Tipton S; Nelson B; Hartwell M
Curr Probl Cancer; 2022 Feb; 46(1):100766. PubMed ID: 34304883
[TBL] [Abstract][Full Text] [Related]
19. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
[TBL] [Abstract][Full Text] [Related]
20. Cancer screening programmes in Italy during the COVID-19 pandemic: an update of a nationwide survey on activity volumes and delayed diagnoses.
Battisti F; Falini P; Gorini G; Sassoli de Bianchi P; Armaroli P; Giubilato P; Giorgi Rossi P; Zorzi M; Battagello J; Senore C; Zappa M; Mantellini P
Ann Ist Super Sanita; 2022; 58(1):16-24. PubMed ID: 35324470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
